CDK1 and autosomal dominant polycystic kidney disease: The study not only generated a well‐characterized, standardized mouse model for ADPKD, but also revealed the involvement of the mTORC1–CDK1/cyclin axis in ADPKD, which leads to new molecular targets for treating this disease.